Sun Damaged Skin Clinical Trial
Official title:
Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects
The purpose of this study is to evaluate the efficacy of topical products in providing protection against the visible light and ultraviolet A1 (UVA1) part of sunlight. Ultraviolet radiation and visible light are both components of sunlight that reach the earth. It is important to test these topical products against visible light and UVA1 because our current sunscreens may not protect against these very well.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05300542 -
Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema
|
N/A | |
Completed |
NCT05865431 -
Singlet Oxygen Quantification After Skin Exposure to Ultraviolet A (UVA) Light
|
N/A | |
Completed |
NCT05926791 -
Photoprotective Effects of a SPF50+ Sunscreen on Skin Genotoxicity Induced by Repeated Chronic Outdoor Sun Exposure
|
||
Completed |
NCT05398237 -
An Assessment of TLR4 and TOPK/PRPK Signaling in Sun Damaged Human Skin Acutely Exposed to Solar Simulated Light
|
N/A | |
Completed |
NCT05162300 -
Same-Day Combination of VI Peel and Botox for Correction of Sun Damage, Fine Lines and Wrinkles
|
Phase 4 | |
Completed |
NCT03110159 -
DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients
|
Phase 1/Phase 2 | |
Completed |
NCT03006185 -
Laser and Microdermabrasion Before Photodynamic Therapy for Actinic Keratoses in Field-cancerized Skin
|
Phase 2 | |
Enrolling by invitation |
NCT03007589 -
Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics
|
N/A |